#Amgen files petition for rehearing #enbanc of #Praluent® written description and enablement issues. Now on our… https://t.co/WWCVIrwZ5x
#Amgen files petition for rehearing #enbanc of #Praluent® written description and enablement issues. Now on our… https://t.co/WWCVIrwZ5x